Inactive Instrument
Guided Therapeutics Inc Stock OTC Bulletin Board
Stocks
US40171F1057
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
OTC Bulletin Board
|
||
| - USD | - |
|
| Market Cap | 24.13M 20.68M 19.35M 17.69M 33.38M 2.31B 33.74M 229M 89.03M 1.16B 90.62M 88.66M 3.84B | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 27.01M 23.15M 21.65M 19.8M 37.36M 2.59B 37.76M 256M 99.64M 1.3B 101M 99.22M 4.3B | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 06/03/2023 |
| Chief Tech/Sci/R&D Officer | 70 | 02/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Faupel
BRD | Director/Board Member | 70 | 01/12/2016 |
John Imhoff
BRD | Director/Board Member | 76 | 10/04/2006 |
Michael James
CHM | Chairman | 67 | 01/10/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.37% | +6.41% | +27.72% | +15.73% | 232B | ||
| +0.49% | +7.72% | +3.49% | -15.87% | 151B | ||
| +0.16% | -4.55% | -20.30% | +25.48% | 132B | ||
| +0.56% | -3.19% | -53.52% | -3.74% | 71.03B | ||
| -1.45% | +0.56% | -16.53% | -12.66% | 52.46B | ||
| -0.31% | -0.92% | +11.48% | +18.34% | 52.16B | ||
| +0.22% | +3.35% | +28.76% | +28.19% | 43.33B | ||
| +0.46% | +2.08% | +37.01% | +49.83% | 40.36B | ||
| -0.88% | +0.80% | -1.85% | +6.74% | 33.51B | ||
| Average | -0.09% | +1.82% | +1.81% | +12.45% | 89.84B | |
| Weighted average by Cap. | +0.13% | +2.78% | +3.59% | +10.03% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7K 6K 5.61K 5.13K 9.68K 670K 9.79K 66.41K 25.82K 337K 26.28K 25.71K 1.11M | 767K 657K 615K 562K 1.06M 73.44M 1.07M 7.28M 2.83M 36.88M 2.88M 2.82M 122M |
| Net income | -2.42M -2.07M -1.94M -1.77M -3.34M -231M -3.38M -22.93M -8.92M -116M -9.08M -8.88M -385M | -3.2M -2.74M -2.56M -2.34M -4.42M -306M -4.47M -30.32M -11.79M -154M -12M -11.74M -508M |
| Net Debt | 1.77M 1.52M 1.42M 1.3M 2.45M 170M 2.48M 16.8M 6.53M 85.15M 6.65M 6.51M 282M | 2.88M 2.46M 2.31M 2.11M 3.98M 275M 4.02M 27.28M 10.61M 138M 10.8M 10.56M 458M |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















